Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Development and Validation of (Bio)Sensors for the Identification of Pathogens

  • Read more about Development and Validation of (Bio)Sensors for the Identification of Pathogens

Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant

  • Read more about Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant

Efficacy of Non-invasive Neuromodulation Treatments for COVID-19 Sequelae

  • Read more about Efficacy of Non-invasive Neuromodulation Treatments for COVID-19 Sequelae

Rehabilitation and Return to Everyday Life for Patients With Long COVID

  • Read more about Rehabilitation and Return to Everyday Life for Patients With Long COVID

COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial

  • Read more about COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial

Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

  • Read more about Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

Bolt CSP-M Holter Study

  • Read more about Bolt CSP-M Holter Study

Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases

  • Read more about Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases

Bioatla, Inc

By jpalfreyman on Mon, 08/05/2024 - 16:08
  • Read more about Bioatla, Inc

Achieve Life Sciences

By jpalfreyman on Mon, 08/05/2024 - 09:45
  • Read more about Achieve Life Sciences

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 73
  • Page 74
  • Page 75
  • Page 76
  • Current page 77
  • Page 78
  • Page 79
  • Page 80
  • Page 81
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA